Derivative exercise or conversion — not an open-market buy.
Traded Jun 16, 2026 · Filed Jun 17, 2026
Hims & Hers Health's PAO sold $229K of Hims & Hers Health shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$229,083
Shares × reported transaction price
36 days after results of May 11, 2026, 55 days before results of Aug 10, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −7.8% | −1.7% | −6.1% |
| 30 days | −7.8% | −0.6% | −7.2% |
| 90 days | −21.1% | +1.0% | −22.0% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
CFO sold ~$261K of Hims & Hers Health
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.